Explore our top-tier plant-derived raw materials featuring superior purity profiles, rigorously tested under ISO9001 and FDA manufacturing specifications.
Frangula Emodin (1,3,8-trihydroxy-6-methylanthraquinone), isolated primarily from the bark of *Rhamnus frangula* (commonly known as alder buckthorn), is occupying a rapidly growing footprint in global pharmaceutical, nutraceutical, and chemical synthesis sectors. As modern health demands shift toward natural active compounds with high physiological activity, Emodin serves as a critical biomarker and therapeutic target molecule.
From a commercial perspective, the sourcing of *Rhamnus frangula* bark is concentrated within Northern, Central, and Eastern Europe, where natural forests and managed agricultural cultivation ensure a steady biomass supply. Historically valued for its purgative properties, modern research has opened new avenues. Today, global pharmaceutical manufacturers and dietary supplement formulators source Frangula Emodin for its proven anti-inflammatory, anti-microbial, and prospective oncology properties.
For B2B buyers, securing high-purity Frangula Emodin (ranging from 95% to 98% HPLC assay standard) involves validating extraction pathways that comply with European Pharmacopoeia (EP) and United States Pharmacopeia (USP) guidelines, while ensuring pesticide and heavy-metal residues remain below strict international limits.
Sourcing Frangula Emodin requires a detailed understanding of the chemical extraction roadmap. Historically, extraction relied heavily on maceration and hot Soxhlet methods using organic solvents like ethanol or methanol. While effective, these older procedures posed significant environmental and chemical residue challenges.
Today, leading chemical and botanical manufacturing entities like Chengdu Chenlv Herb Co., Ltd. utilize cutting-edge methodologies designed to maximize yield and compound stability:
Anthraquinones in the raw bark exist largely as glycosides (frangulins). Enzymatic pre-treatments hydrolyze these glycosides into free anthraquinone aglycones (Emodin), significantly elevating subsequent yield parameters.
Utilizing carbon dioxide at supercritical state or optimized aqueous-ethanol solvent ratios under pressure, target compounds are targeted selectively, preventing thermal degradation.
Using macroporous adsorption resins and targeted elution sequences, we isolate and purify the active aglycone fraction. Multiple crystallization runs ensure HPLC assay levels exceed 98.5% with absolute color consistency.
Analyzing key structural shifts shaping the botanical chemical distribution and procurement industry globally.
Regulatory authorities such as the EFSA in Europe and the FDA in the United States are placing strict focus on origin identification. Suppliers must provide DNA barcoding of raw *Rhamnus frangula* bark and complete mass-balance flow sheets.
The transition from crude, semi-standardized extracts to customized active pharmaceutical ingredients (APIs) requires rigorous analytical testing. HPLC-DAD and LC-MS assay parameters must be supplied for every production batch.
Chemical distributors are prioritizing manufacturers who implement circular economy protocols, reuse processing solvents, and recycle post-extraction plant waste into organic agricultural fertilizers.
| Active Ingredient Specification | Primary Industrial Sector | Recommended Sourcing Purity | Analytical Verification Method | Global Regulatory Status |
|---|---|---|---|---|
| Frangula Emodin >98% | Pharmaceutical Formulation / Oncology Research | 98% - 99% HPLC standard | HPLC-DAD / LC-MS/MS | EP / USP Monographs |
| Standardized Alder Buckthorn Extract | Nutraceutical / OTC Laxatives | 10% - 20% Cascarosides / Anthraquinones | UV-Vis / HPLC profiling | FDA NDI / EU Novel Foods Compliant |
| Frangula Emodin 95% | Cosmeceutical Skincare / Anti-inflammatory | 95% HPLC standard | HPLC / GC-MS | IECIC Listed (China / International) |
| Crude Bark Extracts | Agricultural Bio-control agents | Raw extracts / 5% active marker | HPLC standardization | EPA Registered / Organic farm inputs allowed |
Chengdu Chenlv Herb Co., Ltd. (referred to as "Chenlv Herb") was established in 2012 as a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-quality natural raw materials, the company serves diverse industries, including pharmaceuticals, health supplements, food, and cosmetics.
Frangula Emodin provides diverse biological capabilities that make it key to solving complex cross-sector development challenges.
Emodin serves as a precursor molecule in the synthesis of diacerein (an anti-osteoarthritis therapeutic agent). Furthermore, clinical studies suggest Emodin participates in cellular signal transduction pathways, exhibiting potent anti-tumor activities by inducing apoptosis in diverse oncology models.
Applied in gut-health and metabolic regulatory formulas. Due to its impact on the gut-microbiome and regulation of lipid absorption pathways, dietary supplement providers utilize standard Emodin isolates in weight management and metabolic health solutions.
Modern animal husbandry faces challenges with antibiotic-free protocols. Frangula Emodin helps reduce systemic inflammation and regulates gut flora in aquaculture, swine, and poultry populations, boosting immune defense without chemical residues.
Chenlv Herb provides one-stop contract manufacturing and bespoke botanical extraction services tailored to your exact purity, mesh size, and regulatory specifications.
Detailing custom purity targets, volume commitments, and target regulatory profiles (FDA, EFSA, CFDA).
Source: Chengdu Chenlv Herb
Establishing target pricing, raw materials analysis, and chemical validation thresholds.
Executing chemical supply contracts and distributing small-batch pilot samples for verification.
Industrial scale-up run, post-run testing, CoA validation, and temperature-controlled global shipping.
Choose Chengdu Chenlv Herb Co., Ltd. for products and manufacturing protocols that consistently surpass expectations.
Equipped with state-of-the-art laboratory infrastructure, our researchers optimize extraction runs to maximize active compound concentration while minimizing solvent usage.
Our raw material harvesting processes align with natural rejuvenation cycles, protecting ecosystem biodiversity while maintaining supply chain resilience.
Every shipment is backed by clean certificates of analysis (CoA) detailing heavy metals, pesticides, residual solvents, micro-pathogens, and precise HPLC assays.
Our facility runs under rigorous GMP-standard processes and has obtained certifications from ISO9001, ISO22000, HALAL, KOSHER, and FDA facility registration.
Answering key industry and technical queries about sourcing, verifying, and formulating with Frangula Emodin.
Insights from the field on raw material pricing, biotechnology exhibitions, and global manufacturing opportunities.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season comes to an end, supply-demand dynamics and cost considerations are driving key shifts in product availability.
As a key industry event, CPHI China 2025 will showcase leading developments in chemical and botanical extraction. Join our technical sales team to discuss contract manufacturing opportunities.
The 92nd API China Fair opens in Guangzhou from May 21-23, 2025. Discover our updated portfolio of high-purity active compounds and customized ingredient processing lines.
A broad selection of botanical extracts and standardized active chemical compounds to support food, cosmetic, and pharmaceutical manufacturing.
Get quarterly whitepapers, price forecasts, and industry analysis on high-purity active chemical components directly to your inbox.
Contact US & Sourcing Request
Chenlv Herb